These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37597212)

  • 1. CLEC11A expression as a prognostic biomarker in correlation to immune cells of gastric cancer.
    Fang W; Wan D; Yu Y; Zhang L
    Biomol Biomed; 2024 Jan; 24(1):101-124. PubMed ID: 37597212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UBR1 is a prognostic biomarker and therapeutic target associated with immune cell infiltration in gastric cancer.
    Yuan W; Han J; Chen C; Qiu Y; Xu Y; Huang Y; Chen Z; Xu A; Sun M
    Aging (Albany NY); 2024 Aug; 16(16):12029-12049. PubMed ID: 39181686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of CLEC11A and its derived immune signature in gastric cancer.
    Zheng Q; Gong Z; Li B; Cheng R; Luo W; Huang C; Wang H
    Front Immunol; 2024; 15():1324959. PubMed ID: 38348052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
    Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
    Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of ZHX2 predicts poor prognosis and is correlated with immune infiltration in gastric cancer.
    Cheng A; Guo X; Dai X; Wang Z
    FEBS Open Bio; 2021 Jun; 11(6):1785-1798. PubMed ID: 33837660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of LAMA4 on Prognosis and Its Correlation with Immune Infiltration in Gastric Cancer.
    Wang M; Li C; Liu Y; Wang Z
    Biomed Res Int; 2021; 2021():6428873. PubMed ID: 34414238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer.
    Hou W; Kong L; Hou Z; Ji H
    BMC Med Genomics; 2022 Oct; 15(1):225. PubMed ID: 36316684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FASTKD1 as a diagnostic and prognostic biomarker for STAD: Insights into m6A modification and immune infiltration.
    Yang Y; Gao Y; Liu XS; Huang ZM; Zhang Y; Zhang YH; Liu ZY; Chen YX; Pei ZJ
    Exp Ther Med; 2024 Aug; 28(2):305. PubMed ID: 38873045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased IGFBP7 Expression Correlates with Poor Prognosis and Immune Infiltration in Gastric Cancer.
    Zhao Q; Zhao R; Song C; Wang H; Rong J; Wang F; Yan L; Song Y; Xie Y
    J Cancer; 2021; 12(5):1343-1355. PubMed ID: 33531979
    [No Abstract]   [Full Text] [Related]  

  • 10. Integrin β5, a noninvasive diagnostic biomarker, is associated with unfavorable prognosis and immunotherapy efficacy in gastric cancer.
    Cheng Y; Lin X; Xu H; Xu M; Xie W; Zeng J; Cui B; Cheng Z; Zhao J; Sun Y
    BMC Gastroenterol; 2024 Oct; 24(1):362. PubMed ID: 39394072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schlafen family is a prognostic biomarker and corresponds with immune infiltration in gastric cancer.
    Xu J; Chen S; Liang J; Hao T; Wang H; Liu G; Jin X; Li H; Zhang J; Zhang C; He Y
    Front Immunol; 2022; 13():922138. PubMed ID: 36090985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Impact of Aberrantly Expressed Protein-coding Gene Associated With Gastric Cancer's Regulatory T Cells, Based on Online Databases.
    Zhang Z; Shao X; Wu H; Su X; Wang G; Zhu L; Ji Z
    Altern Ther Health Med; 2023 Apr; 29(3):160-165. PubMed ID: 36735714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer.
    Deng H; Li T; Wei F; Han W; Xu X; Zhang Y
    Pathol Oncol Res; 2023; 29():1610893. PubMed ID: 36741965
    [No Abstract]   [Full Text] [Related]  

  • 14. GGT5 facilitates migration and invasion through the induction of epithelial-mesenchymal transformation in gastric cancer.
    Luo Z; Chen Y; Chen B; Zhao Z; Wu R; Ren J
    BMC Med Genomics; 2024 Apr; 17(1):82. PubMed ID: 38581025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UHRF1 Could Be a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Hepatocellular Carcinoma.
    Li D; Chen B; Zeng Y; Wang H
    Int J Gen Med; 2021; 14():6769-6776. PubMed ID: 34675635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 17. ANXA9 as a novel prognostic biomarker associated with immune infiltrates in gastric cancer.
    Zhang T; Yu S; Zhao S
    PeerJ; 2021; 9():e12605. PubMed ID: 35003923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-Regulated MISP Is Associated With Poor Prognosis and Immune Infiltration in Pancreatic Ductal Adenocarcinoma.
    Huang X; Zhao L; Jin Y; Wang Z; Li T; Xu H; Wang Q; Wang L
    Front Oncol; 2022; 12():827051. PubMed ID: 35433491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
    Yang KS; Xu CQ; Lv J
    Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Endothelial Marker TEM7 is a Prognostic Biomarker and Correlating with Immune Infiltrates in Gastric Cancer.
    Geng L; Chen S; Gong Y; Zhou Y; Yang H; Tang L
    Int J Gen Med; 2021; 14():10155-10171. PubMed ID: 34992436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.